| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Mar―26 |
Extracellular Vesicles Loaded with Long Antisense RNAs Repress Severe Acute Respiratory Syndrome Coronavirus 2 Infection |
Adi Idris, Surya Shrivastava, Aroon Supramaniam, Roslyn M. Ray, Galina Shevchenko, Dhruba Acharya, et al. (+2) Nigel A.J. McMillan, Kevin V. Morris |
| 2 |
[GO] |
2023―Oct―02 |
Highly Potent Antisense Oligonucleotides Locked Nucleic Acid Gapmers Targeting the SARS-CoV-2 RNA Genome |
Vita Dauksaite, Ali Tas, Falk Wachowius, Anouk Spruit, Martijn J. van Hemert, Eric J. Snijder, et al. (+2) Eric P. van der Veer, Anton Jan van Zonneveld |
| 3 |
[GO] |
2022―Jan―13 |
Combining Heparin and a FX/Xa Aptamer to Reduce Thrombin Generation in Cardiopulmonary Bypass and COVID-19 |
Charlene V. Chabata, James W. Frederiksen, Lyra B. Olson, Ibtehaj A. Naqvi, Sharon E. Hall, Ruwan Gunaratne, et al. (+4) Bryan D. Kraft, Loretta G. Que, Lingye Chen, Bruce A. Sullenger |
| 4 |
[GO] |
2021―May―07 |
What Do COVID-19 Vaccines Tell Us About Nucleic Acid Delivery In Vivo? |
Michael Hadjiargyrou |
| 5 |
[GO] |
2020―Apr―16 |
Oligonucleotides and the COVID-19 Pandemic: A Perspective |
John J. Rossi, Daniel Rossi |
|
